Results 41 to 50 of about 8,944 (172)
The demodex: the non-incriminated suspect of chronic blepharitis
We report the case of a 55-year-old patient, followed in ophthalmology for recurrent chronic blepharitis for 5 years. The ophthalmological examination found a 20/20 visual acuity in both eyes, conjunctival hyperemia, instability of the tear film with a ...
Aymane Ridallah, Lalla Ouafaa Cherkaoui
doaj +1 more source
Darier disease—A review highlighting new insights from the Darier Disease International Task Force
This review provides a global, clinically focused overview of DD, detailing cutaneous and extracutaneous manifestations, disease classification and severity scoring. It emphasizes early recognition, multidisciplinary management and practical guidance for dermatologists to apply evidence‐based care in diverse skin phototypes. Abstract Darier disease (DD)
Sofia Labbouz +49 more
wiley +1 more source
Real‐World Efficacy and Systemic Immune Modulation Upon Tralokinumab Treatment in Atopic Dermatitis
ABSTRACT Background Tralokinumab, an interleukin‐13 (IL‐13) monoclonal antibody, has shown clinical efficacy in randomized trials for moderate‐to‐severe atopic dermatitis (AD). This study aims to evaluate clinical and immunological outcome upon tralokinumab treatment in a real‐world cohort of patients with moderate‐to‐severe AD. Methods We recruited 81
Meslina Almaci +3 more
wiley +1 more source
Recalcitrant Eyelid Lupus Treated With Topical Ruxolitinib
ABSTRACT Lupus of the eyelids, or lupus blepharitis, is a rare and localized form of chronic cutaneous lupus. The use of topical corticosteroids is limited in this sensitive area due to the risk of adverse events. We present a case of eyelid lupus, with histological confirmation, resistant to multiple lines of treatment, successfully treated with ...
Clémence Bertold +6 more
wiley +1 more source
Blepharitis is a chronic condition and full recovery is difficult to achieve. It requires good patient compliance and an individual treatment regime. There are many conditions which can cause blepharitis, and it is essential to find the cause to give the proper treatment. There is scarce evidence for the recommended guidelines.
Jordal, Oda Marie +2 more
openaire
Demodex Infestation in Patients With Atopic Dermatitis Treated With Dupilumab: A Case–Control Study
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory skin disease in which dupilumab, an interleukin‐4 receptor alpha antagonist, has become a cornerstone therapy for moderate‐to‐severe disease. However, persistent facial and neck erythema and related symptoms have been increasingly reported during dupilumab treatment, and the underlying ...
Pinar Dursun +2 more
wiley +1 more source
Abstract Purpose Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but may cause immune‐related adverse events (irAEs), including dry eye disease (DED). This study aimed to quantify the incidence of ICI‐associated DED and to evaluate factors contributing to variability across studies.
Kai‐Yang Chen +2 more
wiley +1 more source
Blepharitis — Allergic and Not Only
. Blepharitis is a very common disease in ophthalmology, dermatology, and allergist practice. It can be acute or chronic. Acute blepharitis is most often caused by viruses (Herpes simplex and Varicella zoster) and bacteria (Staphylococcus).
O. M. Besh +3 more
doaj +1 more source
Abstract The global demand for intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy continues to rise, straining ophthalmic capacity worldwide. Task shifting from physicians to trained non‐physician healthcare professionals has emerged as a potential strategy to expand service delivery.
Trang Truong Laursen +4 more
wiley +1 more source
S1‐Leitlinie Schweißdrüsenkarzinom
Zusammenfassung Die aktuelle Einteilung der Schweißdrüsenkarzinome erfolgt nach histomorphologischen Charakteristika und unterscheidet mehr als 20 Entitäten. Es sind meist Patienten höheren, bei einigen Subtypen aber auch mittleren und jüngeren, Lebensalters betroffen. Die Mehrheit der Tumoren entsteht de novo.
Mirjana Ziemer +19 more
wiley +1 more source

